Explore Biotech Companies

Septerna is a clinical-stage biotech company focused on discovering and advancing novel oral small molecule medicines for G protein-coupled receptors (GPCRs).

📍 South SF, CA

Senti Bio is a clinical-stage biotech company developing next-gen cell & gene therapies using proprietary Gene Circuits for incurable diseases.

📍 South SF, CA

Rigel Pharmaceuticals is a biotechnology company focused on discovering, developing, and providing novel small molecule therapies for autoimmune diseases, cancer, and metabolic disorders.

📍 South SF, CA

RAPT Therapeutics is a clinical-stage biopharma company developing novel therapies for inflammatory, immunologic diseases, and cancer.

📍 South SF, CA

R2M Pharma accelerates drug discovery, offering small molecule development services from early lead to Phase 1 clinical trials.

📍 South SF, CA

Quince Therapeutics is a late-stage biotech company focused on rare diseases and Alzheimer's treatment, leveraging patient biology for innovative therapeutics.

📍 South SF, CA

Quanta Therapeutics develops small molecules targeting RAS-driven cancers using allosteric modulation.

📍 South SF, CA

QLSF Biotherapeutics is an innovative immuno-oncology startup focused on developing novel therapies to treat cancer by modulating the tumor microenvironment.

📍 South SF, CA

PRC Clinical is a specialized CRO offering full-service clinical trial management for biotech, pharma, and regenerative medicine globally, with 20+ years of experience.

📍 South SF, CA

Pliant Therapeutics is a clinical-stage biopharma company focused on developing integrin-based treatments for fibrotic diseases.

📍 South SF, CA

Plasmidsaurus offers genome sequencing services, pioneering whole plasmid sequencing and other innovative solutions for biotech and pharmaceutical companies.

📍 South SF, CA

Parvus Therapeutics develops proprietary pMHC nanomedicine drug candidates (Navacims™) to treat autoimmune diseases by restoring immune tolerance.

📍 South SF, CA

ORIC Pharmaceuticals is a clinical-stage biopharma company developing therapies to overcome cancer resistance and improve patient lives.

📍 South SF, CA

Opna Bio is a clinical-stage biopharmaceutical company focused on discovering and developing novel oncology therapeutics, targeting key regulators of cancer.

📍 South SF, CA

Nura Bio is a clinical-stage biopharma company developing small molecule, neuroprotective therapies targeting axon degeneration and neuroinflammation in neurological diseases.

📍 South SF, CA

Noetik is an AI-native biotech company using machine learning to discover and develop precision cancer therapies, focusing on AI Cancer Immunotherapy Discovery.

📍 South SF, CA

Nkarta is a clinical-stage biotech developing allogeneic NK cell therapies for cancer and autoimmune disease using its cell engineering platform.

📍 South SF, CA

Nine Square Therapeutics develops small molecules for neurodegenerative diseases using ML-enabled cell profiling and chemistry.

📍 South SF, CA

NGM Biopharmaceuticals is a clinical-stage biopharma company focused on developing novel medicines for diseases like Type 2 Diabetes, with a pipeline spanning multiple therapeutic areas.

📍 South SF, CA

Neuron23 is a clinical-stage biotech company using AI-drug discovery for precision medicines targeting neurological and immunological diseases.

📍 South SF, CA

Neopeutics is an early-stage drug discovery contract research partner offering cost-effective tools and technologies to enhance the drug discovery process.

📍 South SF, CA

Moonwalk Biosciences is a genomic medicine company pioneering precision epigenetic therapeutics by targeting the epigenetic code to reprogram cells.

📍 South SF, CA

Mission Bio offers a unique single-cell multi-omics platform for DNA and protein analysis, enabling precision medicine discovery and development.

📍 South SF, CA

Mirvie is a biotech company using its RNA platform to predict pregnancy complications, like preeclampsia, through non-invasive blood tests.

📍 South SF, CA